Computation of the Binding Affinities of Catechol-O-methyltransferase Inhibitors: Multisubstate Relative Free Energy Calculations

被引:46
作者
Nuno Palma, P. [1 ]
Bonifacio, Maria Joao [1 ]
Loureiro, Ana Isabel [1 ]
Soares-da-Silva, Patricio [1 ]
机构
[1] BIAL, Dept Res & Dev, P-4745457 S Mamede Do Coronado, Portugal
关键词
multisubstate free energy calculations; free energy perturbation; protein-ligand binding affinity; COMT inhibitor; BIA; 9-1067; Parkinson's disease; PERIPHERALLY SELECTIVE INHIBITOR; MOLECULAR-DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; GENETIC ALGORITHM; TRANSITION-STATE; COMT INHIBITORS; PROTEIN-LIGAND; ENZYME; METHYLATION; EFFICIENCY;
D O I
10.1002/jcc.22926
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Alchemical free energy simulations are amongst the most accurate techniques for the computation of the free energy changes associated with noncovalent proteinligand interactions. A procedure is presented to estimate the relative binding free energies of several ligands to the same protein target where multiple, low-energy configurational substates might coexist, as opposed to one unique structure. The contributions of all individual substates were estimated, explicitly, with the free energy perturbation method, and combined in a rigorous fashion to compute the overall relative binding free energies and dissociation constants. It is shown that, unless the most stable bound forms are known a priori, inaccurate results may be obtained if the contributions of multiple substates are ignored. The method was applied to study the complex formed between human catechol-O-methyltransferase and BIA 9-1067, a newly developed tight-binding inhibitor that is currently under clinical evaluation for the therapy of Parkinson's disease. Our results reveal an exceptionally high-binding affinity (Kd in subpicomolar range) and provide insightful clues on the interactions and mechanism of inhibition. The inhibitor is, itself, a slowly reacting substrate of the target enzyme and is released from the complex in the form of O-methylated product. By comparing the experimental catalytic rate (kcat) and the estimated dissociation rate (koff) constants of the enzyme-inhibitor complex, one can conclude that the observed inhibition potency (Ki) is primarily dependent on the catalytic rate constant of the inhibitor's O-methylation, rather than the rate constant of dissociation of the complex. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:970 / 986
页数:17
相关论文
共 66 条
[1]  
[Anonymous], 2009, DESM MOL DYN SYST
[2]  
[Anonymous], 2009, MAESTR VERS 9
[3]  
AXELROD J, 1958, J BIOL CHEM, V233, P702
[4]   EFFICIENT ESTIMATION OF FREE-ENERGY DIFFERENCES FROM MONTE-CARLO DATA [J].
BENNETT, CH .
JOURNAL OF COMPUTATIONAL PHYSICS, 1976, 22 (02) :245-268
[5]   AVOIDING SINGULARITIES AND NUMERICAL INSTABILITIES IN FREE-ENERGY CALCULATIONS BASED ON MOLECULAR SIMULATIONS [J].
BEUTLER, TC ;
MARK, AE ;
VANSCHAIK, RC ;
GERBER, PR ;
VANGUNSTEREN, WF .
CHEMICAL PHYSICS LETTERS, 1994, 222 (06) :529-539
[6]   FREE-ENERGY VIA MOLECULAR SIMULATION - APPLICATIONS TO CHEMICAL AND BIOMOLECULAR SYSTEMS [J].
BEVERIDGE, DL ;
DICAPUA, FM .
ANNUAL REVIEW OF BIOPHYSICS AND BIOPHYSICAL CHEMISTRY, 1989, 18 :431-492
[7]   Catechol-O-methyltransferase and its inhibitors in Parkinson's disease [J].
Bonifacio, Maria Joao ;
Palma, P. Nuno ;
Almeida, Luis ;
Soares-da-Silva, Patricio .
CNS DRUG REVIEWS, 2007, 13 (03) :352-379
[8]   Kinetics and crystal structure of catechol-O-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application [J].
Bonifácio, MJ ;
Archer, M ;
Rodrigues, ML ;
Matias, PM ;
Learmonth, DA ;
Carrondo, MA ;
Soares-da-Silva, P .
MOLECULAR PHARMACOLOGY, 2002, 62 (04) :795-805
[9]   New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease [J].
Bonifati, V ;
Meco, G .
PHARMACOLOGY & THERAPEUTICS, 1999, 81 (01) :1-36
[10]  
Bowers K. J., 2006, P 2006 ACM IEEE C SU